Proapoptotic and anticarcinogenic properties of leviusculoside G (LSG) isolated from the starfish Henricia leviuscula and a probable mechanism of these effects were investigated in human leukemia HL-60, THP-1, and mouse skin JB6 Cl41 cells, using a variety of assessments, including a cell viability (MTS) assay, flow cytometry, anchorage-independent soft agar assay, luciferase assay, and western-blotting. Application of LSG at nontoxic doses induced apoptosis in cancer cells and decreased cell transformation. This compound exerted its actions, at least in part, through the induction of p53-dependent apoptosis and inhibition of AP-1, NF-κB, and ERKs activities.
The search for natural compounds that inhibit malignant transformation of normal cells and induce apoptosis of tumor cells opens a prospect for selection of new pharmaceutical leads. Glycosylated steroids are the usual secondary metabolites of starfish. These compounds demonstrate a wide spectrum of biological activities including embryotoxic, hemolytic, antiviral, antifungal, antiinflammatory, hypotensive, and neuritogenic effects [1] [2] [3] . Leviusculoside G (LSG, Figure 1 ) was isolated from the Far Eastern starfish Henricia leviuscula and showed hemolytic and neuritogenic activities [4, 5] . However, its proapoptotic and/or other anticarcinogenic properties have not been fully investigated. Herein, we report anticancer activities of LSG and provide some detail regarding a probable molecular mechanism of its action.
Flow cytometry was used to study the proapototic properties of LSG. Either HL-60 or THP-1 cells were treated with increasing concentrations of LSG and harvested after 24 h. Apoptosis of these cells was assessed by flow cytometry using Annexin V-FITC and propidium iodide double staining. Apoptosis was clearly induced by LSG in a dose-dependent manner ( Figure  2 , A and B). HL-60 cells (A) were more sensitive to LSG compared to THP-1 cells (B). LSG (40 μM) induced apoptosis in 70% of HL 60 cells; whereas the same concentration induced apoptosis in 30% of the THP-1 cells. LSG was also assayed for cancer-preventive (anticarcinogenic) activity using the anchorageindependent JB6 P + Cl41 cell transformation soft agar assay. Based on our previous experience [6] [7] [8] [9] [10] , inhibition of cell transformation is a good indication that a compound will have an effective cancerpreventive activity. Results indicated that LSG inhibited JB6 P + Cl41 cell transformation induced by EGF in a dose-dependent manner and at non-toxic concentrations ( Figure 3 ). Toxicity of LSG for JB6 Cl41 cells was determined by the MTS cell viability assay and results indicated that even 80 μM LSG was non-toxic to these cells ( Figure 4 ).
To elucidate a possible mechanism of LSG's anticancer action, the effect of the compound on AP-1, NF-κB and p53 transcriptional activation was investigated in JB6 Cl41 cells stably expressing a luciferase reporter gene controlled by an AP-1, NF-κB, or p53 DNA binding sequence.
The role of AP-1 transcriptional activation in proliferation, differentiation, tumor promotion, and EGF-induced malignant transformation of JB6 P + cells is well known [11] [12] [13] [14] . Our results show that LSG is a new inhibitor of AP-1 transcriptional activity including that induced by EGF ( Figure 5 ).
The NF-κB transcription factor is also implicated in the activation of a large number of genes, including those responsive to infection and inflammation, and is reported to be involved in the suppression of apoptosis [15, 16] . In contrast, the tumor suppressor protein p53 is part of the cell's emergency response team that functions to regulate negatively cell growth following damage by inducing cell cycle arrest and apoptosis [17] [18] [19] . In our study, LSG at non-toxic concentrations and in a dose-dependent manner suppressed NF-κB transactivation, but induced p53-dependent transcriptional activity in JB6 Cl41 cells ( Figure 6 ). The effect of LSG on phosphorylation of ERKs was then studied. The extracellular signal-regulated kinases (ERKs) function in the control of cell division. Inhibitors of these enzymes are being explored as anticancer agents [20, 21] . Moreover, ERKs are able to activate oncogenic transcription factors, including AP-1, NF-κB, and c-Myc [20, 21] .
Western blot results indicated that LSG inhibited EGF-induced ERKs phosphorylation and activation in a dose-dependent manner at non-toxic concentrations (20-40 μM; Figure 7 ).
Steroidal glycosides from starfish were reported to possess moderate cytotoxic activity against various cancer cell lines [22, 23] . However nothing has been reported regarding the molecular mechanism, intracellular targets, or signaling pathways mediating the anticancer effect of steroidal glycosides isolated from starfish. Further, information regarding the cancer preventive properties of these natural products has not yet been reported.
Using flow cytometry and an anchorage-independent soft agar assay, we found that LSG induced apoptosis in human cancer cell lines, HL-60 and THP-1, and suppressed malignant transformation of mouse JB6 P + Cl41 epidermal skin cells at nontoxic concentrations of 20-50 μM. We also showed that at the same doses it induced p53-dependent transcriptional activity and inhibited EGF-induced ERKs phosphorylation and AP-1-and NF-κBdependent transcriptional activity in JB6 Cl41 cells. These observations suggest that the proapoptotic and cancer-preventive effects of LSG may be due to inhibition of oncogenic factors and induction of p53dependent apoptosis in cancer cells. We thus conclude that steroidal glycosides from starfish represent a prospective group of marine secondary metabolites that might be highly effective anticancer and cancer-preventive compounds and should be further studied. Reagents: LSG (Figure 1) was isolated from the starfish Henricia leviuscula, as described previously, and was pure in accordance with NMR, MS, TLC, and HPLC data [4] . Minimum essential medium (MEM), and RPMI medium were purchased from Gibco Invitrogen Corporation (Carlsbad, CA, USA Cell culture: The JB6 P + Cl41 mouse epidermal skin cell line and its stable transfectants JB6-LucAP-1, JB6-LucNF-κB, or JB6-Lucp53 (PG-13) cells were cultured in monolayers at 37°C and 5% CO 2 in MEM containing 5% FBS, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin [24] . The human cancer cell lines, HL-60 and THP-1 were obtained from the American Type Culture Collection (Rockville, MD, USA) and were cultured at 37°C in 5% CO 2 in RPMI containing 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin and 100 μg/mL streptomycin. Information regarding the genetic background of these cell lines is available online.
Experimental

Apoptosis assessed by flow cytometry:
Early and late apoptosis induced by LSG were analyzed by flow cytometry. HL-60 or THP-1 cells (3×10 5 per dish), were grown in 6-cm dishes for 12 h in 10% FBS-RPMI. Then, cells were treated with LSG in 10% FBS-RPMI for 24 h. After treatment with LSG, cells were harvested, washed by centrifugation at 1,000 rpm (170 rcf) for 5 min and processed for detection of early and late apoptosis using Annexin V-FITC and propidium iodide staining according to the manufacturer's protocol. In brief, cells (1×10 5 -5×10 5 ) were collected after centrifugation, and resuspended in 500 μL of 1× binding buffer (Annexin V-FITC Apoptosis Detection kit, Medical & Biological Laboratories). Then, 5 μL of Annexin V-FITC and 5 μL of propidium iodide were added, and the cells were incubated in the dark at room temperature for 5 min and analyzed by flow cytometry. Results are shown in Figure 2 as percent of early or late apoptosis.
Anchorage-independent transformation assay:
The cancer-preventive effect of LSG was evaluated using an anchorage-independent neoplastic transformation assay. EGF (10 ng/mL) was used for stimulating neoplastic transformation of JB6 P + Cl41 cells. The assay was carried out in six-well tissue culture plates. Mouse JB6 P + Cl41 cells (8 × 10 3 /mL) were treated with various concentrations of LSG in 1 mL of 0.33% basal medium Eagle (BME) agar containing 10% FBS over 3 mL of 0.5% BME agar containing 10% FBS and various concentration of LSG. The cultures were maintained in a 37°C, 5% CO 2 incubator for 1 week and cell colonies were then scored. Results are shown in Figure 3 as a number of colonies relative to untreated control or EGF-control cells.
Assay for AP-1, NF-κB, or p53-dependent transcriptional activity:
AP-1, NF-κB, or p53dependent transcriptional activity was assayed with a JB6 P + Cl41 cell line stably expressing a luciferase reporter gene controlled by an AP-1, NF-κB, or p53 DNA binding sequence. Viable cells (8×10 3 ) suspended in 100 μL of 5% FBS-MEM were added into each well of a 96-well plate. Plates were incubated overnight and then starved for 24 h in 0.1% FBS-MEM. Then, cells were treated with various concentrations of LSG for 1 h, and EGF (10 ng/mL) was (or was not) added. After incubation with substances for 24 h, the cells were disrupted for 1 h at room temperature with lysis buffer (0.1 M potassium phosphate buffer at pH 7.8, 1% Triton X-100, 1 mM DTT, 2 mM EDTA). Then, 30 μL of lysate from each well were transferred into a plate for luminescent analysis and luciferase activity was measured. Results are expressed in Figures 5 and 6 as an AP-1, NF-κB, or p53 -dependent transcriptional activity relative to untreated control cells (1 unit).
Cell viability assay:
The effect of LSG on cell viability was evaluated using MTS reduction into its formazan product [25] . The JB6 P + Cl41 cells were cultured for 12 h in 96-well plates (6,000 per well). The media were then replaced with corresponding media containing 0.1% FBS and LSG at various concentrations in a total volume of 0.1 mL and the cells were incubated for 22 h. Then, 20 μL of the MTS reagent was added into each well and MTS reduction was measured 2 h later spectrophotometrically at 492 and 690 nm as background using the Multiskan MS microplate reader (Labsystems, Finland). Results are shown in Figure 4 and represent the percentage of LSG-treated cells relative to untreated control cells.
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Natural Product Communications Vol. 3 (10) 2008 1579 Western blot analysis. JB6 P + Cl41 cells were plated (1 × 10 6 /10-cm dish) in 5% FBS-MEM and allowed to attach overnight. Then, the cells were starved in 0.1% FBS-MEM for 24 h and incubated with the indicated concentrations of LSG for 1 h and then with EGF (10 ng/mL) for 30 min. Then, cells were washed with PBS and disrupted with 200 μL buffer (1×PBS, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol Na 3 VO 4 , 1 mmol aprotinin, and 1 mmol phenylmethylsulfonyl fluoride). The samples were sonicated and centrifuged at 15,000 × g for 15 min. The quantity of protein was measured by the Bradford method [26] and normalized against controls. The samples were heated to 95°C for 5 min, cooled on ice, and centrifuged at 15,000 × g for 5 min. The samples (30 μg) were then resolved by 8% SDS-PAGE. Immunoblotting analysis of phosphorylated ERK1/2 kinases was carried out using specific antibodies against phosphorylated sites of ERK1/2 (Thr202/Tyr204). Results are shown in Figure 7 .
